[1] Feghali J, Yang W, Huang J. Updates in chronic subdural hematoma: epidemiology, etiology, pathogenesis, treatment, and outcome [J]. World Neurosurg, 2020, 141: 339-345.
[2] Stubbs D J, Vivian M E, Davies B M, et al. Incidence of chronic subdural haematoma: a single-centre exploration of the effects of an ageing population with a review of the literature [J]. Acta Neurochir (Wien), 2021, 163(9): 2629-2637.
[3] Edlmann E, Whitfield P C, Kolias A, et al. Pathogenesis of chronic subdural hematoma: a cohort evidencing de novo and transformational origins [J]. J Neurotrauma, 2021, 38(18): 2580-2589.
[4] 郭 雨, 赵 凯, 杨明飞. 慢性硬膜下血肿形成机制及栓塞治疗研究进展 [J]. 2021,37(6):637-639.
[5] Bounajem M T, Campbell R A, Denorme F, et al. Paradigms in chronic subdural hematoma pathophysiology: Current treatments and new directions [J]. J Trauma Acute Care Surg, 2021, 91(6): e134-e141.
[6] Tamura R, Sato M, Yoshida K, et al. History and current progress of chronic subdural hematoma [J]. J Neurol Sci, 2021, 429: 118066.
[7] Hart R G, Pearce L A, Gorelick P B, et al. Aspirin use and risk of subdural hematoma: updated meta-analysis of randomized trials [J]. J Stroke Cerebrovasc Dis, 2021, 30(8): 105911.
[8] Hamou H A, Clusmann H, Schulz J B, et al. Chronic subdural hematoma [J]. Dtsch Arztebl Int, 2022, 119(12): 208-213.
[9] 张 鹏, 李育平, 汤 灿. 慢性硬膜下血肿与凝血相关因素的研究进展 [J]. 中国微侵袭神经外科杂志, 2020,25(1):43-45.
[10] Duncan P W, Bushnell C, Sissine M, et al. Comprehensive stroke care and outcomes: time for a paradigm shift [J]. Stroke, 2021, 52(1): 385-393.